The National Institute of Mental Health and the Eunice Kenndy Shriver National Institute of Child Health and Human Development invite applications for their rare genetic disorders as a window into the genetic architecture of mental disorders funding opportunity. This supports collaborative research to characterise the underlying genetic architecture of diverse neuropsychiatric phenotypes within and across rare genetic disorders and identify the shared genetic risk across rare and idiopathic neuropsychiatric disorders. Projects will use genome-wide data to comprehensively assess the contribution of genetic variation to the variable expressivity and incomplete penetrance of neuropsychiatric phenotypes across rare genetic disorders.
This opportunity uses the following mechanisms:
- U01 (clinical trial not allowed) Research Project – Cooperative Agreements funding mechanism.
- Collaborative U01 (clinical trial not allowed) Research Project – Cooperative Agreements funding mechanism.
Funding & Duration
The total amount awarded and the number of awards will depend on the quality, duration, costs and the receipt of a sufficient number of meritorious applications. Application budgets are not limited but must reflect the actual needs of the proposed project. Projects may last up to five years.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Date
- 9 July 2018 – Letter of Intent (LOI) submitted directly to Sponsor.
- 2 August 2018 – full applications submitted for internal review.
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review